☆ 4.7 Article

Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells

FRONTIERS IN PHARMACOLOGY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, Research & Experimental

Silencing of Long Non-coding RNA H19 Alleviates Lipopoly-saccharide (LPS)-induced Apoptosis and Inflammation Injury by Regulating miR-140-5p/TLR4 Axis in Cell Models of Pneumonia

Hong Yang

Summary: This study aims to investigate the function and regulatory mechanism of lncRNA H19 in LPS-induced cell models of pneumonia. The results showed that H19 and TLR4 were up-regulated, while miR-140-5p was down-regulated. H19 inhibited apoptosis and inflammation through the miR-140-5p/TLR4 pathway in LPS-induced WI-38 cells.

CURRENT MOLECULAR MEDICINE (2023)

添加到收藏夹

Article Clinical Neurology

Givinostat for Becker muscular dystrophy: A randomized, placebo-controlled, double-blind study

Giacomo P. Comi et al.

Summary: This study investigated the efficacy and safety of givinostat in adults with Becker muscular dystrophy (BMD). The primary endpoint of statistical superiority for mean change in total fibrosis was not achieved. However, MRI assessments suggested that givinostat may potentially prevent or slow down BMD disease progression.

FRONTIERS IN NEUROLOGY (2023)

添加到收藏夹

Article Oncology

Givinostat Inhibition of Sp1-dependent MGMT Expression Sensitizes Glioma Stem Cells to Temozolomide

Yurika Nakagawa-Saito et al.

Summary: This study found that Givinostat can enhance the cytotoxic activity of Temozolomide against glioma stem cells (GSCs) by inhibiting Sp1-dependent O6-methylguanine-DNA methyltransferase (MGMT) expression, suggesting that the combination of Givinostat and Temozolomide could be an effective therapeutic strategy to overcome treatment resistance in glioblastoma.

ANTICANCER RESEARCH (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies

Martina Sandona et al.

Summary: Histone deacetylases (HDACs) regulate the deacetylation of proteins, affecting cellular processes. Abnormal HDAC expression or activity is associated with various pathologies, making them potential therapeutic targets. For example, HDAC inhibitors have shown positive effects in preclinical and clinical studies for Duchenne Muscular Dystrophy (DMD). Understanding the cellular functions of HDACs in dystrophic muscles provides new insights for the development of effective therapeutic approaches.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oncogenic BRAF and p53 Interplay in Melanoma Cells and the Effects of the HDAC Inhibitor ITF2357 (Givinostat)

Adriana Celesia et al.

Summary: We previously showed that the HDAC inhibitor ITF2357 targets oncogenic BRAF in melanoma cells. In this study, we found that oncogenic BRAF localizes to the nucleus of these cells and ITF2357 reduces both nuclear and cytosolic BRAF levels. We also observed an interaction between BRAF and oncogenic p53, and ITF2357 decreased levels of both proteins in certain melanoma cells.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Medicine, Research & Experimental

HDAC inhibitor ITF2357 reduces resistance of mutant-KRAS non-small cell lung cancer to pemetrexed through a HDAC2/miR-130a-3p-dependent mechanism

Jian Cui et al.

Summary: The HDAC inhibitor ITF2357 restores miR-130a-3p expression by inhibiting HDAC2, thereby repressing Rad51 and ultimately diminishing the resistance of mutant KRAS NSCLC to pemetrexed.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

添加到收藏夹

Article Oncology

Combined inhibition of histone deacetylase and cytidine deaminase improves epigenetic potency of decitabine in colorectal adenocarcinomas

Zijiao Tang et al.

Summary: This study evaluates the efficacy of treatment drugs in colon cancer cell lines and patient-derived colon cancer cell lines, and finds that the combination of decitabine, histone deacetylase inhibitor PBA, and cytidine deaminase inhibitor THU significantly improves the drug potency and promotes drug uptake. These findings have the potential to be applied in clinical trials for colorectal adenocarcinoma patients.

CLINICAL EPIGENETICS (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

LncRNA H19 mediates BMP9-induced angiogenesis in mesenchymal stem cells by promoting the p53-Notch1 angiogenic signaling axis

Chengcheng Du et al.

Summary: In this study, we investigated the regulatory mechanism of long non-coding RNA H19 (H19) in BMP9-induced angiogenesis. We demonstrated that H19 was highly expressed in mesenchymal stem cells (MSCs), and silencing H19 attenuated BMP9-induced osteogenesis and angiogenesis in MSCs. Furthermore, down-regulation of H19 inhibited BMP9-mediated blood vessel formation and subsequent bone formation. Mechanistically, H19 promoted the phosphorylation of p53 by direct interaction and phosphorylation binding, thereby enhancing Notch1 expression and activation of Notch1-targeting genes.

GENES & DISEASES (2023)

添加到收藏夹

Article Oncology

Long Non-Coding RNA H19 Expression Correlates with Autophagy Process in Adrenocortical Carcinoma

Pietro Di Fazio et al.

Summary: Adrenocortical carcinoma (ACC) is characterized by poor prognosis and high mortality. Using deacetylase inhibitors (DACi) can restore H19 and autophagy markers in ACC cells, triggering cell death. This suggests a novel treatment strategy for patients with this severe malignancy.

CANCER INVESTIGATION (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation

Hsueh-Yun Lee et al.

Summary: This study focuses on the development of benzamide-based compounds as potential HDAC1/2 inhibitors for colorectal cancer treatment. Compound 9 is identified as a selective HDAC inhibitor with significant anticancer activity against colorectal cancer cells. The study also investigates the molecular regulatory mechanisms of compound 9, demonstrating its potential in apoptosis activation, cell cycle arrest induction, DNA damage facilitation, and cancer migration suppression in colorectal cancer cells.

CHEMICO-BIOLOGICAL INTERACTIONS (2022)

添加到收藏夹

Article Cell Biology

Modulation of lncRNA H19 enhances resveratrol-inhibited cancer cell proliferation and migration by regulating endoplasmic reticulum stress

Tianye Li et al.

Summary: Resveratrol inhibits the survival of gastric tumor cells by promoting apoptosis, autophagy, and endoplasmic reticulum stress. It also alters the expression of several long non-coding RNAs, and knockdown of H19 enhances the therapeutic effect of resveratrol.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2022)

添加到收藏夹

Article Surgery

Increased Expression of Long Non-coding RNA H19 is Associated With Colon Cancer Recurrence

Stephen J. O'Brien et al.

Summary: The study found an association between H19 expression in colon cancer tissue and patients' recurrence-free and overall survival, with high H19 expression linked to reduced recurrence-free survival. Increased H19 expression was also associated with advanced stage of tumor disease.

JOURNAL OF SURGICAL RESEARCH (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

HDAC Inhibitors: Innovative Strategies for Their Design and Applications

Mateusz Dasko et al.

Summary: HDACs are a group of epigenetic metalloenzymes that play crucial roles in gene transcription and regulation, cell proliferation, and various cellular processes. Abnormal expression of HDACs is associated with the development of cancer and neurodegenerative diseases. Therefore, innovative strategies and compounds targeting the inhibition and degradation of HDACs are of great significance for the treatment and early diagnosis of these diseases.

MOLECULES (2022)

添加到收藏夹

Article Cell Biology

Integrated Chromatin Accessibility and Transcriptome Landscapes of 5-Fluorouracil-Resistant Colon Cancer Cells

Bishu Zhang et al.

Summary: This study explored chromatin accessibility and transcription changes in 5-FU resistant colon cancer cells, identifying differentially expressed mRNAs, lncRNAs, and miRNAs related to 5-FU resistance, as well as differentially accessible regions positively correlated with gene expression changes. This analysis identified potential therapeutic targets and regulatory elements associated with 5-FU resistance.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Histone Deacetylases and their Inhibitors in Colorectal Cancer Therapy: Current Evidence and Future Considerations

Nikolaos Garmpis et al.

Summary: Colorectal cancer is a heterogeneous group of gastrointestinal tract tumors, and its pathogenesis involves multiple factors. Histone deacetylases have been found to be over-expressed in CRC and play an important role in its molecular pathophysiology.

CURRENT MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Long noncoding RNA H19 mediates neural stem/progenitor cells proliferation, differentiation and apoptosis through the p53 signaling pathway after ischemic stroke

Li Gan et al.

Summary: H19 plays an important role in NSPCs induced by OGD/R, promoting cell proliferation and differentiation by inhibiting the p53 signaling pathway, while inhibiting cell apoptosis.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

添加到收藏夹

Article Immunology

LncRNA H19 acts as miR-301a-3p sponge to alleviate lung injury in mice with sepsis by regulating Adcy1

Jingjing Hou et al.

Summary: In this study, it was found that lncRNA H19 could alleviate sepsis-induced lung injury by interacting with miR-301a-3p and upregulating Adcy1.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2022)

添加到收藏夹

Article Oncology

HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Maria Serena Roca et al.

Summary: This study investigated the potential of domatinostat in sensitizing PDAC to standard chemotherapeutic treatment. The results showed that domatinostat can enhance the sensitivity of PDAC to chemotherapy drugs by targeting cancer stem cells and inducing oxidative stress. Mechanistically, domatinostat reduces the expression and function of FOXM1, a transcription factor involved in stemness and DNA repair. The expression of FOXM1 is also correlated with the prognosis of chemotherapy-treated PDAC patients.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

添加到收藏夹

Article Oncology

Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells

Chiara Zichittella et al.

Summary: This study investigated the role of hypoxia-induced miR-675-5p in 5-FU resistance in colorectal cancer cells. The results showed that inhibiting miR-675-5p enhanced the apoptotic signal induced by 5-FU treatment and identified Caspase-3 as a target of miR-675-5p. These findings suggest that inhibition of hypoxia-induced miR-675-5p could be a potential strategy to overcome chemoresistance.

BMC CANCER (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer

Siddhartha Das Pramanik et al.

Summary: This review examines the role of HDACs in cancer treatment. While clinical trials with HDACi as monotherapy have had mixed results, combination therapy with other anticancer drugs has shown synergistic effects, increasing efficacy and decreasing toxicity.

FRONTIERS IN CHEMISTRY (2022)

添加到收藏夹

Article Oncology

Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics

Lorenzo Taiarol et al.

Summary: This study demonstrates the anti-tumor activity of the pan-HDAC inhibitor Givinostat and a suitable liposomal formulation. The liposome-Givinostat formulation improves the drug's half-life and brain delivery in a mouse model. Additionally, this formulation shows anti-tumor activity in in vitro models.

CANCERS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

The Antigastric Cancer Effect of Triptolide is Associated With H19/NF-κB/FLIP Axis

Weiwei Yuan et al.

Summary: The study found that pretreatment of gastric cancer cells with triptolide can enhance its anti-tumor effect. This effect is dependent on the disruption of the H19/miR-204-5p/NF-kappa B/FLIP axis.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Genetics & Heredity

The role of lncRNA H19 in tumorigenesis and drug resistance of human Cancers

Xun Zhang et al.

Summary: Drug resistance is a major obstacle in cancer therapy, and lncRNA H19 plays a critical role in tumor development and multiple drug resistance. This review summarizes the relationship between lncRNA H19 and tumorigenesis, as well as the mechanisms of drug resistance caused by it.

FRONTIERS IN GENETICS (2022)

添加到收藏夹

Review Oncology

HDACi: The Columbus' Egg in Improving Cancer Treatment and Reducing Neurotoxicity?

Angelica Squarzoni et al.

Summary: This review analyzes the role of histone deacetylases (HDACs) in the nervous system to identify the most promising candidate for an effective antineoplastic drug with limited neurotoxicity.

CANCERS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis

Adriana Celesia et al.

Summary: This study compared the effects of two HDAC inhibitors, ITF2357 and SAHA, in melanoma cells with the BRAF V600E oncogenic mutation. Results showed that ITF2357 was more effective than SAHA in reducing the viability of BRAF-mutated melanoma cells, and it also decreased the expression of oncogenic BRAF protein and induced a switch from autophagy to classic apoptosis.

BIOMEDICINES (2022)

添加到收藏夹

Article Oncology

Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p/WNK3 signaling axis in NSCLC cells

Xueshan Zhao et al.

Summary: The lncRNA H19 plays a role in regulating radiosensitivity in NSCLC cells and may serve as a potential therapeutic target and impact the effectiveness of anti-tumor radiotherapy in NSCLC.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Histone Deacetylase Inhibitors: A Promising Therapeutic Alternative for Endometrial Carcinoma

Iason Psilopatis et al.

Summary: Histone deacetylase inhibitors have shown promising therapeutic potential in endometrial cancer by inhibiting tumor growth, inducing cell cycle arrest and apoptosis. Histone acetylation plays a critical role in the development and progression of endometrial carcinoma. Additional clinical trials are needed to further evaluate the clinical utility and safety of these agents in treating patients with endometrial cancer.

DISEASE MARKERS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Bioinformatic Tools for the Analysis and Prediction of ncRNA Interactions

Andres Rincon-Riveros et al.

Summary: Noncoding RNAs play key roles in gene expression regulation by interacting with other biological molecules, and computational biology can enhance our understanding of these interactions. Experimental findings drive advancements in computational methods, which in turn provide new insights for experimental validation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Oncology

The double-edged sword of H19 lncRNA: Insights into cancer therapy

Yun Wei Shermane Lim et al.

Summary: H19 long non-coding RNA has dual roles in cancer, acting as both an oncogene and a suppressor gene in tumor development. It plays a crucial role in cancer therapy through various mechanisms, including its applications in recombinant vectors, chemoresistance, epigenetic regulation, alteration of tumor microenvironment, and cancer immunotherapy, as well as its relationship with the tumor suppressor gene p53.

CANCER LETTERS (2021)

添加到收藏夹

Article Neurosciences

Long noncoding RNA H19 contributes to the proliferation and autophagy of glioma cells through mTOR/ULK1 pathway

Wei Zhao et al.

Summary: The study confirms that H19 promotes the proliferation and autophagy of glioma cells through the mTOR/ULK1 pathway.

NEUROREPORT (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

LncRNA-H19 Drives Cardiomyocyte Senescence by Targeting miR-19a/socs1/p53 Axis

Yuting Zhuang et al.

Summary: The study revealed that the long noncoding RNA H19 plays a pro-senescence role in cardiomyocytes by targeting the miR-19a/SOCS1/p53/p21 pathway. This provides a novel theoretical basis for finding new therapeutic targets for senescence-associated cardiac diseases.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Selective Inhibition of HDAC Class I Sensitizes Leukemia and Neuroblastoma Cells to Anticancer Drugs

Elmira Vagapova et al.

Summary: The resistance of leukemia and neuroblastoma cells to anticancer therapy remains a challenge, but targeting HDAC with hydrazostat has shown potential in reactivating RTK expression and enhancing the efficacy of RTK inhibitors. This study reveals a promising strategy to overcome drug resistance in these diseases.

BIOMEDICINES (2021)

添加到收藏夹

Article Cell Biology

Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma

Katharina Koerholz et al.

Summary: The study found that pan-HDAC inhibitors can induce autophagy in neuroblastoma, and their combination with autophagy modulating drugs suppresses tumor growth of high-risk neuroblastoma cells.

CELLS (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy

M. Janaki Ramaiah et al.

Summary: Genetic and epigenetic factors play crucial roles in tumor initiation and progression, with HDAC inhibitors showing promise in inducing tumor suppression by regulating chromatin conformation.

LIFE SCIENCES (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Targeting HDAC8 to ameliorate skeletal muscle differentiation in Duchenne muscular dystrophy

Marco Spreafico et al.

Summary: Research shows that HDAC8 is overexpressed in DMD patients and dystrophic zebrafish, and selective inhibition of HDAC8 can rescue skeletal muscle defects. This suggests that targeting HDAC8 specifically may be a valuable therapeutic approach in treating this pathology.

PHARMACOLOGICAL RESEARCH (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

LncRNA H19 Upregulation Participates in the Response of Glioma Cells to Radiation

Yanbei Kuang et al.

Summary: Previous studies have shown that the radiation resistance of glioma is a major factor in radiotherapy failure. Emerging evidence suggests that the long non-coding RNA H19 plays a crucial role in regulating the radiosensitivity of glioma cells by modulating processes such as cell cycle arrest, apoptosis, and DNA synthesis after irradiation, ultimately enhancing radioresistance. Further investigation is needed to fully understand the underlying molecular mechanisms involved.

BIOMED RESEARCH INTERNATIONAL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

LncRNA H19: A novel oncogene in multiple cancers

Jun Yang et al.

Summary: Long non-coding RNAs (lncRNAs) play important roles in cancers, among which H19 has attracted attention due to its abnormal expression in malignant tumors and involvement in malignant progression in various cancers.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

添加到收藏夹

Review Chemistry, Medicinal

Histone deacetylase (HDAC) inhibitors in cancer: a patent review (2017-present)

Chunlong Zhao et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Roles and Mechanisms of lncRNAs in Liver Fibrosis

Zhi He et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Oncology

Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy

Maria Mrakovcic et al.

CANCERS (2020)

添加到收藏夹

Article Oncology

A 6 lncRNA-Based Risk Score System for Predicting the Recurrence of Colon Adenocarcinoma Patients

Haojie Yang et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Oncology

LncRNA H19 promotes triple-negative breast cancer cells invasion and metastasis through the p53/TNFAIP8 pathway

Yang Li et al.

CANCER CELL INTERNATIONAL (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Hypoxia-Induced miR-675-5p Supports β-Catenin Nuclear Localization by Regulating GSK3-β Activity in Colorectal Cancer Cell Lines

Laura Saieva et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

p62: Friend or Foe? Evidences forOncoJanusandNeuroJanusRoles

Sonia Emanuele et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Oncology

Long Non-Coding RNA H19 Promotes Proliferation, Migration and Invasion and Inhibits Apoptosis of Breast Cancer Cells by Targeting miR-491-5p/ZNF703 Axis

Yongkun Wang et al.

CANCER MANAGEMENT AND RESEARCH (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors

Ana J. Rodrigues Moita et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma via AMPK-FOXO1-ULK1 signaling axis-mediated autophagy

Qiang Xiao et al.

THERANOSTICS (2020)

添加到收藏夹

Article Medicine, General & Internal

Trichostatin A activates FOXO1 and induces autophagy in osteosarcoma

Yunjuan Bai et al.

ARCHIVES OF MEDICAL SCIENCE (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Long Non Coding RNA H19: A New Player in Hypoxia-Induced Multiple Myeloma Cell Dissemination

Chiara Corrado et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

添加到收藏夹

Article Cell Biology

Temporal expression and functional analysis of long non-coding RNAs in colorectal cancer initiation

Lei Dai et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)

添加到收藏夹

Article Oncology

Interplay of lncRNA H19/miR-675 and lncRNA NEAT1/miR-204 in breast cancer

Volkmar Mueller et al.

MOLECULAR ONCOLOGY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy

Srimanta Patra et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature

Huan Zhou et al.

BIOMED RESEARCH INTERNATIONAL (2019)

添加到收藏夹

Article Oncology

In vitro and in vivo studies on the association of long non-coding RNAs H19 and urothelial cancer associated 1 with the susceptibility to 5-fluorouracil in rectal cancer

Yasuyuki Yokoyama et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2019)

添加到收藏夹

Review Oncology

Long non-coding RNA H19 and cancer: A competing endogenous RNA

Yafen Ye et al.

BULLETIN DU CANCER (2019)

添加到收藏夹

Review Oncology

Long Non-Coding RNAs in Thyroid Cancer: Implications for Pathogenesis, Diagnosis, and Therapy

Mohammad-Reza Mahmoudian-Sani et al.

ONCOLOGY RESEARCH AND TREATMENT (2019)

添加到收藏夹

Article Medicine, Research & Experimental

Overexpression of long non-coding RNA H19 promotes invasion and autophagy via the PI3K/AKT/mTOR pathways in trophoblast cells

Jin Xu et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

添加到收藏夹

Article Oncology

Lnc RNA H19 is associated with poor prognosis in breast cancer patients and promotes cancer stemness

Hidetaka Shima et al.

BREAST CANCER RESEARCH AND TREATMENT (2018)

添加到收藏夹

Review Cell Biology

Long non-coding RNAs in ischemic stroke

Mei-Hua Bao et al.

CELL DEATH & DISEASE (2018)

添加到收藏夹

Article Oncology

Long non-coding RNA H19 promotes the migration and invasion of colon cancer cells via MAPK signaling pathway

Weiwei Yang et al.

ONCOLOGY LETTERS (2018)

添加到收藏夹

Review Nutrition & Dietetics

Targeting Histone Deacetylases with Natural and Synthetic Agents: An Emerging Anticancer Strategy

Amit Kumar Singh et al.

NUTRIENTS (2018)

添加到收藏夹

Article Oncology

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma

Marta Di Martile et al.

ONCOGENESIS (2018)

添加到收藏夹

Review Oncology

Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi

Amila Suraweera et al.

FRONTIERS IN ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil

Tetsuya Minegaki et al.

ONCOLOGY LETTERS (2018)

添加到收藏夹

Article Cell Biology

Long non-coding RNA H19 confers 5-Fu resistance in colorectal cancer by promoting SIRT1-mediated autophagy

Meng Wang et al.

CELL DEATH & DISEASE (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

Histone Deacetylase Inhibitors as Anticancer Drugs

Tomas Eckschlager et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

添加到收藏夹

Article Cell & Tissue Engineering

Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence

Luciana O. Almeida et al.

STEM CELL RESEARCH (2017)

添加到收藏夹

Article Oncology

MiR-675-5p supports hypoxia induced epithelial to mesenchymal transition in colon cancer cells

Viviana Costa et al.

ONCOTARGET (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The lncRNA H19 Promotes Cell Proliferation by Competitively Binding to miR-200a and Derepressing β-Catenin Expression in Colorectal Cancer

Weiwei Yang et al.

BIOMED RESEARCH INTERNATIONAL (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

miR-675 promotes disease progression of non-small cell lung cancer via activating NF-κB signaling pathway

Y. Feng et al.

CELLULAR AND MOLECULAR BIOLOGY (2017)

添加到收藏夹

Article Medicine, Research & Experimental

MiR675-5p Acts on HIF-1 alpha to Sustain Hypoxic Responses: A New Therapeutic Strategy for Glioma

Alessia Lo Dico et al.

THERANOSTICS (2016)

添加到收藏夹

Article Neurosciences

Inhibition of the Autophagy Pathway Synergistically Potentiates the Cytotoxic Activity of Givinostat (ITF2357) on Human Glioblastoma Cancer Stem Cells

Francesca Angeletti et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Sensitization of tumor cells by targeting histone deacetylases

Paola Perego et al.

BIOCHEMICAL PHARMACOLOGY (2012)

添加到收藏夹

Article Biochemistry & Molecular Biology

Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells

Feng Yang et al.

FEBS JOURNAL (2012)

添加到收藏夹

Article Rheumatology

Safety and Efficacy of an Oral Histone Deacetylase Inhibitor in Systemic-Onset Juvenile Idiopathic Arthritis

Jelena Vojinovic et al.

ARTHRITIS AND RHEUMATISM (2011)

添加到收藏夹

Article Biochemistry & Molecular Biology

HDAC Inhibition in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis

Jelena Vojinovic et al.

MOLECULAR MEDICINE (2011)

添加到收藏夹

Article Gastroenterology & Hepatology

Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice

R. Glauben et al.

GUT (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.